title: The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.
abstract: The Society for Vascular Surgery (SVS) and the American Venous Forum (AVF) have developed clinical practice guidelines for the care of patients with varicose veins of the lower limbs and pelvis. The document also includes recommendations on the management of superficial and perforating vein incompetence in patients with associated, more advanced chronic venous diseases (CVDs), including edema, skin changes, or venous ulcers. Recommendations of the Venous Guideline Committee are based on the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system as strong (GRADE 1) if the benefits clearly outweigh the risks, burden, and costs. The suggestions are weak (GRADE 2) if the benefits are closely balanced with risks and burden. The level of available evidence to support the evaluation or treatment can be of high (A), medium (B), or low or very low (C) quality. The key recommendations of these guidelines are: We recommend that in patients with varicose veins or more severe CVD, a complete history and detailed physical examination are complemented by duplex ultrasound scanning of the deep and superficial veins (GRADE 1A). We recommend that the CEAP classification is used for patients with CVD (GRADE 1A) and that the revised Venous Clinical Severity Score is used to assess treatment outcome (GRADE 1B). We suggest compression therapy for patients with symptomatic varicose veins (GRADE 2C) but recommend against compression therapy as the primary treatment if the patient is a candidate for saphenous vein ablation (GRADE 1B). We recommend compression therapy as the primary treatment to aid healing of venous ulceration (GRADE 1B). To decrease the recurrence of venous ulcers, we recommend ablation of the incompetent superficial veins in addition to compression therapy (GRADE 1A). For treatment of the incompetent great saphenous vein (GSV), we recommend endovenous thermal ablation (radiofrequency or laser) rather than high ligation and inversion stripping of the saphenous vein to the level of the knee (GRADE 1B). We recommend phlebectomy or sclerotherapy to treat varicose tributaries (GRADE 1B) and suggest foam sclerotherapy as an option for the treatment of the incompetent saphenous vein (GRADE 2C). We recommend against selective treatment of perforating vein incompetence in patients with simple varicose veins (CEAP class C(2); GRADE 1B), but we suggest treatment of pathologic perforating veins (outward flow duration ≥500 ms, vein diameter ≥3.5 mm) located underneath healed or active ulcers (CEAP class C(5)-C(6); GRADE 2B). We suggest treatment of pelvic congestion syndrome and pelvic varices with coil embolization, plugs, or transcatheter sclerotherapy, used alone or together (GRADE 2B).
authors.affiliation: Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA. gloviczki.peter@mayo.edu
authors.forename: Peter
authors.initials: P
authors.lastname: Gloviczki
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Comerota
authors.forename: Michael C
authors.initials: MC
authors.lastname: Dalsing
authors.forename: Bo G
authors.initials: BG
authors.lastname: Eklof
authors.forename: David L
authors.initials: DL
authors.lastname: Gillespie
authors.forename: Monika L
authors.initials: ML
authors.lastname: Gloviczki
authors.forename: Joann M
authors.initials: JM
authors.lastname: Lohr
authors.forename: Robert B
authors.initials: RB
authors.lastname: McLafferty
authors.forename: Mark H
authors.initials: MH
authors.lastname: Meissner
authors.forename: M Hassan
authors.initials: MH
authors.lastname: Murad
authors.forename: Frank T
authors.initials: FT
authors.lastname: Padberg
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Pappas
authors.forename: Marc A
authors.initials: MA
authors.lastname: Passman
authors.forename: Joseph D
authors.initials: JD
authors.lastname: Raffetto
authors.forename: Michael A
authors.initials: MA
authors.lastname: Vasquez
authors.forename: Thomas W
authors.initials: TW
authors.lastname: Wakefield
mesh_terms: D002317:Cardiovascular Agents / Q000627:therapeutic use; D058128:Compression Bandages / Q000592:standards; D057510:Endovascular Procedures / Q000009:adverse effects / Q000592:standards*; D019317:Evidence-Based Medicine; D006801:Humans; D018579:Patient Selection; D011237:Predictive Value of Tests; D012008:Recurrence; D018570:Risk Assessment; D015911:Sclerotherapy / Q000009:adverse effects / Q000592:standards*; D012720:Severity of Illness Index; D012955:Societies, Medical / Q000592:standards*; D016896:Treatment Outcome; D014481:United States; D014648:Varicose Veins / Q000145:classification / Q000175:diagnosis / Q000628:therapy*; D014656:Vascular Surgical Procedures / Q000009:adverse effects / Q000592:standards*; D014689:Venous Insufficiency / Q000145:classification / Q000175:diagnosis / Q000628:therapy*
chemical_list: D002317:Cardiovascular Agents